Monitoring the immune system using digital nanotechnologies with single-molecule resolution
Duration:
July 2021–June 2025
Project summary
This research is highly multidisciplinary and encompasses the fields of nanotechnology, biology, and medical science, to develop new nano-diagnostic tools to better understand the drivers of long-COVID, auto-immune diseases and cancer. Tools such as SERS nanoparticle synthesis, microfluidic devices and the Immunostorm chip, allow for the ultra-sensitive detection of specific biomarkers. This can open a unique window into many diseases and has the potential to deliver information about the underlying biological mechanisms occurring in patients.
Project members
Lead investigator
Researchers